CYP2B6Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port‐au‐Prince, Haiti
Open Access
- 15 September 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (6), 955-964
- https://doi.org/10.1086/605126
Abstract
BackgroundPolymorphisms in CYP2B6 are known to predict increased steady-state plasma concentrations of efavirenz. We characterized relationships betweKeywords
This publication has 31 references indexed in Scilit:
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in LiverJournal of Pharmacology and Experimental Therapeutics, 2008
- Racial Differences in Virologic Failure Associated With Adherence and Quality of Life on Efavirenz-Containing Regimens for Initial HIV TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 ExpressionDrug Metabolism and Disposition, 2007
- Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7Pharmacogenetics and Genomics, 2007
- Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected IndividualsClinical Pharmacology & Therapeutics, 2007
- Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 InfectionA Randomized Controlled TrialJAMA, 2006
- Full Validation of an Analytical Method for the HIV-Protease Inhibitor Atazanavir in Combination With 8 Other Antiretroviral Agents and its Applicability to Therapeutic Drug MonitoringTherapeutic Drug Monitoring, 2006
- Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenzPharmacogenetics and Genomics, 2006
- Pharmacogenetics of Long‐Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group StudyThe Journal of Infectious Diseases, 2005
- Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patientsPharmacogenetics and Genomics, 2005